Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

Credence Behavioral Health opened its doors in Lynchburg. Now, the outpatient clinic is serving over 1,700 patients, and ...

Mental health is not just depression, schizophrenia, a mood disorder, anxiety; it has all of the things. We are trying to ...

Market reaction to recent readouts from Compass Pathways and Beckley Psytech/atai in treatment-resistant depression speaks to ...

We need a resurgence of enthusiasm and encouragement for those able to develop alternative and more effective treatments, so ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a clinical-stage neuropsychiatry company, announced UK MHRA approval to initiate EMBRACE, the second pivota ...

After drowning in his hot tub at 54, Matthew Perry's doctor pleaded guilty to distributing the drug that helped kill him.

On Friday, July 18, the Lynchburg Regional Business Alliance and Credence Behavioral Health officially cut the ribbon to ...

Florida is stepping up its efforts to help abate veteran suicide by agreeing to spend $300,000 this year to expand statewide ...

More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia ...